Study of COR388 HCl in Healthy Subjects
Completed · Phase 1 · Has a placebo group
Conditions studied: Healthy Subjects
In brief
The study is a randomized, double-blind, placebo-controlled, dose escalation, first-in-human trial of the safety and tolerability of COR388 HCl in healthy male and female subjects.
Key facts
- Study ID
- NCT03331900
- Run by
- Cortexyme Inc.
- People needed
- 34
- Starts
- 2017-12-11
- Expected to finish
- 2018-04-02
- Last updated by the study team
- 2018-04-18
Who can join
Age: 18 and older, up to 55. Sex: any. Healthy volunteers: accepted.
Where it is running
- Medpace Clinical Pharmacology Unit — Cincinnati, Ohio, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.